Applied Biopharm Consulting Secures Innovation Funding to Advance AI Driven Viral Vector Research

Share this Article

Cork, IRELAND. April 2nd 2026 – Applied Biopharm Consulting Ltd has been awarded an Innovation Voucher from the Local Enterprise Office Cork North & West to support further advancement of its artificial intelligence (AI) driven viral vector research program.

The Innovation Voucher scheme enables Irish SMEs to collaborate with registered knowledge providers, including universities and research institutes, to explore innovation opportunities and address technical challenges. 

Applied Biopharm Consulting will use this support to establish a formal research collaboration with an Irish knowledge provider to validate experimentally its computational platform for engineered viral vector optimisation through laboratory based testing and analysis.

Building on its 2024 feasibility study and subsequent Intellectual Property (IP) Start Grant, the company continues to expand its structured research and development programme focused on next-generation adeno-associated virus (AAV) engineering. The Innovation Voucher will facilitate scientific collaboration and validation activities, supporting the continued evolution of the company’s AI-driven molecular design methodologies.

Applied Biopharm Consulting’s R&D program integrates artificial intelligence, structural bioinformatics and molecular simulation techniques to analyse large datasets of protein structures and predict biomolecular interactions. This data-driven approach is designed to enhance vector targeting, improve gene delivery efficiency and inform the development of advanced biologic design strategies.

Dr. Anthony Newcombe, Managing Director of Applied Biopharm Consulting Ltd, commented:

“The Innovation Voucher offers an important opportunity to collaborate with academic experts and further strengthen the scientific foundations of our viral vector engineering programme. By combining industry-based regulatory and manufacturing expertise with external research capability, we are accelerating the development of innovative viral vector technologies.”

A spokesperson for the Local Enterprise Office Cork North & West added:

“The Innovation Voucher scheme is designed to help innovative Irish companies access research and development expertise. We are pleased to support Applied Biopharm Consulting as it advances its research into AI-driven viral vector engineering, and we look forward to seeing the continued development of this research program.”

The award underscores Applied Biopharm Consulting’s continued investment in research and development while maintaining its core focus on supporting global biopharmaceutical clients in GMP compliance, regulatory CMC, MSAT, quality assurance and technology transfer. The company’s dual approach integrates extensive regulatory and manufacturing expertise with next-generation biologics, positioning it strongly within the evolving advanced therapies landscape.

For more information, please contact:

Anthony Newcombe, Managing Director
Applied Biopharm Consulting Ltd
mailto: anthony.newcombe@appliedbiopharm.com
Mob: +353 (0) 873634486

Sharleen Foody, Senior Enterprise Development Officer
mailto: northcork@leo.corkcoco.ie
Mob: +353(22) 43235

ENDS
Press Release published by

Got News You'd Like To Share With The World?

Press Release Distribution Starts from £95

PR Fire is here to help you stand out!

Using our simple pay-as-you-go portal, just select your targeted industry, and our team will begin custom-building your distribution.
Buy Now